50 Einträge gefunden

21. Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.

    1. Metzner, Karin J
    2. Rauch, Pia
    3. Braun, Patrick
    4. Knechten, Heribert
    5. Ehret, Robert
    6. Korn, Klaus
    7. Kaiser, Rolf

    2011 - Forschungsinformationssystem des UKE
22. Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy.

    1. Zoufaly, Alexander
    2. An der Heiden, M
    3. Kollan, C
    4. Bogner, J R
    5. Fätkenheuer, G
    6. Wasmuth, J C
    7. Stoll, M

    2011 - Forschungsinformationssystem des UKE
23. Gene therapy strategies: can we eradicate HIV?

    1. van Lunzen, Jan
    2. Fehse, Boris
    3. Hauber, Joachim

    2011 - Forschungsinformationssystem des UKE
24. Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients.

    1. Lehmann, Clara
    2. Lafferty, Mark
    3. Garzino-Demo, Alfredo
    4. Jung, Norma
    5. Hartmann, Pia
    6. Fätkenheuer, Gerd
    7. Wolf, Jeffrey S

    2010 - Forschungsinformationssystem des UKE - frei zugänglich
25. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection.

    1. Alter, Galit
    2. Kavanagh, Daniel
    3. Rihn, Suzannah
    4. Luteijn, Rutger
    5. Brooks, David
    6. Oldstone, Michael
    7. van Lunzen, Jan

    2010 - Forschungsinformationssystem des UKE
26. Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report

    1. Schewe, Knud
    2. Noah, Christian
    3. Sirma, Hüseyin
    4. Schmiedel, Stefan
    5. van Lunzen, Jan
    6. Rockstroh, Jürgen Kurt
    7. Schildgen, Oliver

    2010 - Forschungsinformationssystem des UKE
27. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.

    1. Reekie, J
    2. Mocroft, A
    3. Ledergerber, B
    4. Beniowski, M
    5. Clotet, B
    6. van Lunzen, Jan
    7. Chiesi, A

    2010 - Forschungsinformationssystem des UKE
28. Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcome.

    1. Streeck, Hendrik
    2. Jessen, Heiko
    3. Kuecherer, Claudia
    4. Li, Bin
    5. Jessen, Arne B
    6. Dupke, Stephan
    7. Baumgarten, Axel

    2009 - Forschungsinformationssystem des UKE
29. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.

    1. Zoufaly, Alexander
    2. Stellbrink, Hans-Jürgen
    3. Heiden, Matthias An der
    4. Kollan, Christian
    5. Hoffmann, Christian
    6. van Lunzen, Jan
    7. Hamouda, Osamah

    2009 - Forschungsinformationssystem des UKE
30. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.

    1. Schulze Zur Wiesch, Julian
    2. Pieper, Dorothea
    3. Stahmer, Ingrid
    4. Eiermann, Thomas
    5. Buggisch, Peter
    6. Lohse, Ansgar W.
    7. Hauber, Joachim

    2009 - Forschungsinformationssystem des UKE
31. Preferential upregulation of interferon-alpha subtype 2 expression in HIV-1 patients.

    1. Lehmann, C
    2. Taubert, D
    3. Jung, N
    4. Fätkenheuer, G
    5. van Lunzen, Jan
    6. Hartmann, P
    7. Romerio, F

    2009 - Forschungsinformationssystem des UKE
32. [Preliminary first steps are encouraging. Gene therapy against HIV? (interview by Waldtraud Paukstadt)]

    1. van Lunzen, Jan

    2009 - Forschungsinformationssystem des UKE
33. Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.

    1. Steininger, Christoph
    2. Graninger, W
    3. Zoufaly, Alexander
    4. Zöllner, B
    5. Feucht, Heinz Hubert
    6. Kundi, M
    7. Stahmer, I

    2008 - Forschungsinformationssystem des UKE
34. Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

    1. Ortiz, Roberto
    2. Dejesus, Edwin
    3. Khanlou, Homayoon
    4. Voronin, Evgeniy
    5. van Lunzen, Jan
    6. Andrade-Villanueva, Jaime
    7. Fourie, Jan

    2008 - Forschungsinformationssystem des UKE
35. A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.

    1. Mehendale, Sanjay
    2. van Lunzen, Jan
    3. Clumeck, Nathan
    4. Rockstroh, Jurgen
    5. Vets, Eva
    6. Johnson, Philip R
    7. Anklesaria, Pervin

    2008 - Forschungsinformationssystem des UKE
36. Incidence of abacavir hypersensitivity reactions in euroSIDA.

    1. Bannister, Wendy P
    2. Friis-Møller, Nina
    3. Mocroft, Amanda
    4. Viard, Jean-Paul
    5. van Lunzen, Jan
    6. Kirk, Ole
    7. Gargalianos, Panagiotis

    2008 - Forschungsinformationssystem des UKE
37. [Integrase inhibition--a new mode of action in HIV therapy]

    1. van Lunzen, Jan
    2. Degen, Olaf

    2008 - Forschungsinformationssystem des UKE
38. Primary HIV infection presenting as haemolytic crisis in a patient with previously undiagnosed glucose 6-phosphate dehydrogenase deficiency.

    1. Schulze Zur Wiesch, Julian
    2. Wichmann, Dominic
    3. Hennigs, Annette
    4. van Lunzen, Jan
    5. Burchard, Gerd-Dieter
    6. Schmiedel, Stefan

    2008 - Forschungsinformationssystem des UKE
39. Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients.

    1. Lehmann, Clara
    2. Harper, Jill M
    3. Taubert, Dirk
    4. Hartmann, Pia
    5. Fätkenheuer, Gerd
    6. Jung, Norma
    7. van Lunzen, Jan

    2008 - Forschungsinformationssystem des UKE
40. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

    1. Reekie, Joanne
    2. Mocroft, Amanda
    3. Sambatakou, Helen
    4. Machala, Ladislav
    5. Chiesi, Antonio
    6. van Lunzen, Jan
    7. Clumeck, Nathan

    2008 - Forschungsinformationssystem des UKE